Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
about
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasisGlyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death.Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.Plasmepsins as potential targets for new antimalarial therapy.Using small molecules to study big questions in cellular microbiology.Kinetoplastids: related protozoan pathogens, different diseases.Drug targets in Leishmania.Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos.Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia.Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.Molecular docking of cathepsin L inhibitors in the binding site of papain.Characterization of recombinant glutathionylspermidine synthetase/amidase from Crithidia fasciculataBiological characterization of a beta-galactosidase expressing clone of Trypanosoma cruzi CL strain.8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase
P2860
Q27011766-43E22A93-B745-4D1A-8185-B9A93622ADE8Q30387486-B3D0B425-0B04-4CB6-B143-2F5580E1F90FQ30897674-AB51CD66-1840-41BB-8B9C-9FE7DB03570EQ33250030-B525FA98-32B5-4EC4-BE41-05801BCCCC6DQ34782644-8590B1D3-AE97-48F9-89CD-FEEE7EA50C90Q36513308-CC6B0C30-E37A-4984-9D1C-3772DC4BA5DAQ37869809-4512B8CF-6F4D-4013-BDAB-C137B0877D3AQ37998091-D64C1B5B-3DE4-447D-AF72-D6A5633A7342Q38154629-17CE348D-BAEB-4675-905B-ACD050A9FED4Q40987037-F4370FEC-F78B-4251-A256-803059BBF84FQ41824183-948D8962-F10C-4EB2-B2F9-E0D39D0A0500Q41889166-6D9EA2C3-AA3C-469B-9FE0-B52EA8DECBD2Q42094447-AF7BE772-81D8-46A6-9607-4FFCD3798CBCQ44300510-0BDB334B-4132-474A-BD26-85CCF02248D4Q58850134-0BDF30B2-C69B-46CB-AE37-2727423397C1
P2860
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@ast
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@en
type
label
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@ast
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@en
prefLabel
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@ast
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@en
P356
P1476
Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
@en
P2093
Werbovetz KA
P304
P356
10.2174/0929867003374615
P577
2000-08-01T00:00:00Z